Neuphoria Therapeutics board extends rights agreement to October 27, 2027
NEUP•Neuphoria Therapeutics’ board amended its Rights Agreement on October 23, 2026, extending its expiration to close of business on October 27, 2027, unless earlier extended, modified or terminated.
1. Agreement extended
The board entered into an amendment to the Rights Agreement on October 23, 2026. The agreement now expires at close of business on October 27, 2027, unless earlier extended, modified or terminated.
